| Patent Number |
Title Of Patent |
Date Issued |
| 5103019 |
Process for producing 2-amino-nitrides |
April 7, 1992 |
| A novel process for obtaining an .alpha.-amino-nitrile of the formula ##STR1## by reacting a nitrile with a metallic reducing agent to form a metallic imine of the formula ##STR2## and reacting the latter with a cyaniding agent to obtain the corresponding .alpha.-amino-nitril |
| 4942221 |
Process for obtaining .alpha.-amino nitriles and their applications to organic synthesis |
July 17, 1990 |
| The present invention relates to the synthesis of nitriles having an amine function on the adjacent carbon. |
| 4835184 |
Novel pharmaceutical compositions intended to the treatment of neuropathies and promoting the ne |
May 30, 1989 |
| Compositions and method of treating neuropathies resulting from diabetic, non-diabetic, toxic or viral origin and insuring regeneration of damaged nerve fibers by administration of the N,N-dimethyl-biguanide salt of p-chlorophenoxy-acetic acid. |
| 4762855 |
Novel pharmaceutical compositions improving oxygenation of the brain and a process for their pro |
August 9, 1988 |
| 2,2-Bisphenoxy-dimethyl-aminoethane to improve brain disfunction. |
| 4709051 |
Novel aroylpyrroles, their production and their use in immunologic therapy |
November 24, 1987 |
| This invention relates to novel aroylated derivatives of pyrrole. More particularly it provides the novel naphthoyl derivatives of pyrrolyl-2-carboxylic acid having the general formula I: ##STR1## wherein: R.sub.1 is a lower alkyl radical, a phenyl radical or a hydrogen;X is a hydrog |
| 4617315 |
Pharmaceutical compositions having immuno-suppressive properties |
October 14, 1986 |
| This invention relates to novel pharmaceutical compositions having immuno-suppressive activities, the active ingredient of which is a 4-aroyl N-alkyl or aryl pyrrolyl-2 carboxylic acid or a salt thereof.The pharmaceutical compositions have therapeutic utility for treating auto-immune dis |
| 4259509 |
2-Methyl-2-phenoxy-propionic acid derivatives, process for their preparation and therapeutical a |
March 31, 1981 |
| This invention relates to compounds having the formula: ##STR1## which represents the isomer Z, the isomer E or the mixture of both stereoisomers of the oximino group and in which:A represents O or S,X.sup.1 represents a halogen atom, a hydrogen atom or a methyl group,R represents a hydr |
| 4246277 |
Lowering the concentration of plasma triglycerides |
January 20, 1981 |
| The present invention relates to a method of lowering the concentration of plasma triglycerides of a subject in need thereof, which comprises administering an effective but non toxic amount of each isomer or a mixture thereof of compound ##STR1## or pharmaceutically acceptable ad |
| 4239771 |
Water-soluble salts of tienilic acid |
December 16, 1980 |
| The invention provides water-soluble salts of tienilic acid, 2,3-dichloro-4-(2-thienylcarbonyl)-phenoxyacetic acid, and amino acids of the formula ##STR1## in which n is an integer of 1 to 5 and R represents a basic nitrogenous group, preferably an amino group or guanidino group. |
| 4220794 |
Synthetic intermediates for the preparation of diaromatic O-(amino-alkyl)oximes |
September 2, 1980 |
| The present invention relates to compounds having the formula: ##STR1## in which n is an integer from 1 to 4, A is selected from the group consisting of oxygen and sulfur and R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen and C.sub.1-4 alkyl.Thes |
| 4207319 |
Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof |
June 10, 1980 |
| Aromatic compounds having the following formula are disclosed: ##STR1## in which, A in the heterocyclic group is selected from the group of O and S;R.sub.1, R.sub.2, R.sub.3 and R.sub.4, which may be identical or different, are selected from the group consisting of hydrogen, halogen, |
| 4195093 |
Furoyl- and thenoyl-aryloxyalkyl carboxylic acid derivatives, their preparation and their use in |
March 25, 1980 |
| Compounds of the general formula I ##STR1## wherein n represents 0, 1 or 2, A represents oxygen or sulphur, Z represents oxygen or hydroxyimino, X represents hydrogen, or halogen, the dotted lines represent bonds which may be unsaturated or saturated, R.sub.1 and R.sub.2 each rep |
| 4194003 |
New pyrrole derivatives, process for their preparation and therapeutic applications thereof |
March 18, 1980 |
| The present invention relates to a compound selected from the compounds of the formula: ##STR1## in which: R.sup.1 is selected from hydrogen and C.sub.1-4 alkyl,R is selected from C.sub.1-6 alkyl, benzyl and phenyl,Ar is selected from phenyl, phenyl monosubstituted with a group selected |
| 4188388 |
Phenoxy pyridazinones and anorexigenic use thereof |
February 12, 1980 |
| Compounds of the formula I ##STR1## in which R.sub.1 and R.sub.2 each represent a hydrogen atom, a halogen atom, an alkyl group containing 1 to 3 carbon atoms, an alkoxy group containing 1 to 3 carbon atoms or a trifluoromethyl group; and R.sub.3 represents an alkyl group contain |
| 4179516 |
Ethers of 3,4-dihydro-1-benzoxepin-5-one oxime to treat intestinal disorders |
December 18, 1979 |
| Therapeutic compositions, particularly for treating intestinal disorders, and a method of treating colopathics by administering an effective amount of the compositions are described. The compositions contain a therapeutically effective amount of at least one isomer of the oximino gro |
| 4148915 |
Bis(2-phenoxyalkane carboxylic acids) and derivatives thereof and their use as medicaments |
April 10, 1979 |
| Bis (2-phenoxyalkane carboxylic acids) and their esters and salts, as well as a method for their preparation. These compounds are useful for the treatment of hyperlipemia and arteriosclerosis. |
| 4062974 |
Method for treating drepanocytosis |
December 13, 1977 |
| New method for the remedial or prophylactic treatment of drepanocytosis and related syndromes, comprising administering BETA-DIMETHYLAMINO ETHYL ESTER OF PARACHLOROPHENOXY ACETIC ACID or one of its physiologically acceptable acid addition salts, by the IM or oral route. |
